CGS-CIMB analysts Ivy Ng and Nagulan Ravi have maintained “add” on Wilmar, with the same target price of $5.53, although key downsides to the stock include the potential delay or termination to YKA’s IPO and weaker-than-expected crushing or refining margins.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply